AI helps tailor cancer vaccine for dog, but scientists urge caution
An Australian tech entrepreneur used AI tools to help design a personalized mRNA cancer vaccine for his eight-year-old dog, Rosie, after mast cell tumors persisted post-surgery and chemotherapy. DNA sequencing of Rosie’s tumor identified mutations (neoantigens); AI helped select targets, and researchers at the University of New South Wales turned these into an experimental vaccine administered to Rosie, with several tumors shrinking and the dog showing improved energy. However, this is a single case, not a controlled study, so it cannot be taken as a cure and highlights the need for robust testing, ethical safeguards, and careful interpretation of AI-assisted results before broader use.
